Immunosuppressants in advanced clinical development for organ transplantation and selected autoimmune diseases

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.8, Iss.1, 2003-05, pp. : 47-62

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Update on the clinical pharmacogenomics of organ transplantation

By Burckart Gilbert J Amur Shashi

Pharmacogenomics, Vol. 11, Iss. 2, 2010-02 ,pp. : 227-236

Future Medicine

Access to resources Recommend Favorite

Immunosuppressants: Nephrogenic systemic fibrosis (first report with prednisone, tacrolimus and mycophenolate mofetil) after organ transplantation: 2 case reports

Reactions Weekly, Vol. 1, Iss. 1169, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation

By Christine E. Staatz Susan E. Tett

Clinical Pharmacokinetics, Vol. 43, Iss. 10, 2004-01 ,pp. : 623-653

Adis International

Access to resources Recommend Favorite

Clinical pharmacogenetics of immunosuppressive drugs in organ transplantation

By Szekeres Thomas Haushofer Alexander

Pharmacogenomics, Vol. 6, Iss. 2, 2005-03 ,pp. : 163-168

Future Medicine

Access to resources Recommend Favorite

Gout in Solid Organ Transplantation: A Challenging Clinical Problem

By Stamp Lisa Searle Martin

Drugs, Vol. 65, Iss. 18, 2005-01 ,pp. : 2593-2611

Adis International

Access to resources Recommend Favorite